Illumina

ILMN
Delayed Nasdaq - 07/19 10:00:00 pm
293.2USD
-1.79%
Prev.298.5500
Open297.7900
High298.2000
Low291.0000
Volume1 620 592
Financials
Sales 2019 3 622 M
EBIT 2019 1 062 M
Net income 2019 923 M
Finance 2019 2 582 M
Yield 2019 -
P/E ratio 2019 47,5x
P/E ratio 2020 41,0x
EV / Sales2019 11,2x
EV / Sales2020 9,62x
Capitalization 43 100 M
Company
Illumina specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and...
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2019-07-29 Earnings Release
Trading Rating :
Investor Rating :
Latest news
07/17EXCLUSIVE : Woodford biotech stakes first off block in asset sale - source
RE
07/16ILLUMINA : Expands Genomics Accelerator to Cambridge, UK
BU
07/15Stocks to Watch: Circor International, Callon Petroleum, American Airlines, Boeing and More
DJ
07/15Stocks to Watch: Boeing, Gilead Sciences, Facebook, J&J and More
DJ
07/12Ford, Milacron rise; Illumina, US Xpress fall
AQ
07/12Wall St. notches all-time highs on lingering rate-cut optimism
RE
07/12MARKET SNAPSHOT: S&P 500, Dow, Nasdaq Close At Record Levels Again As Bulls Bank On Fed Rate Cut
DJ
07/11ILLUMINA INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance326378378
Spread/Res.-9,9%-22%-22%
Spread/Supp.7,6%7,6%5,1%
Support273273279